Telix Pharmaceuticals (TLPPF) Prepaid Assets (2023 - 2026)
Telix Pharmaceuticals' (TLPPF) quarterly Prepaid Assets came in at $26.7 million in Q2 2026, up 65.91% quarter-over-quarter from $16.1 million in Q4 2025.
Analysis
Telix Pharmaceuticals (TLPPF) Prepaid Assets (2023 - 2026) Analysis & Trends
Telix Pharmaceuticals (TLPPF) has reported Prepaid Assets for 4 consecutive years, with $26.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Prepaid Assets changed N/A year-over-year to $26.7 million in Q2 2026; TTM through Jun 2026 was $26.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $16.1 million, up 17.8% from the prior year.
- Prepaid Assets was $26.7 million for Q2 2026 at Telix Pharmaceuticals, up from $16.1 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $26.7 million in Q2 2026 and troughed at $12.7 million in Q4 2023.
- A 4-year average of $17.3 million and a median of $14.9 million in 2025 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets increased 8.64% in 2024 and rose 16.52% in 2025, its largest moves.
- Over 4 years, Prepaid Assets stood at $12.7 million in 2023, then increased by 8.64% to $13.8 million in 2024, then climbed by 16.52% to $16.1 million in 2025, then surged by 65.91% to $26.7 million in 2026.
- The last three Prepaid Assets figures came in at $26.7 million (Q2 2026), $16.1 million (Q4 2025), and $13.8 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 212.49 Bn | 198.50 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.93 Bn | 177.75 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.39 Bn | 124.53 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.17 Bn | 74.18 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.05 Bn | 55.87 Bn | 1.37 Bn |
| 6 | Moderna | 55.19 Bn | 50.05 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.99 Bn | 30.68 Bn | 992.69 Mn |
| 8 | Biogen | 31.30 Bn | 30.01 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.91 Bn | 29.91 Bn | 1.16 Mn |
| 10 | Telix Pharmaceuticals | 3.72 Bn | 3.43 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.69 Mn |
| Dec 31, 2025 | 16.09 Mn |
| Dec 31, 2024 | 13.81 Mn |
| Dec 31, 2023 | 12.71 Mn |